Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Search for stocks (e.g., AAPL, GOOGL, AMZN)
PMCB logo

PMCB

NSC
PharmaCyte Biotech Inc.
HealthcareBiotechnology
Watchlists:
Last updated: Friday 18th July 2025
1.02
-0.10 (-8.93%)
Prev Close:1.12
Open:1.1
Bid:1.0
Ask:1.14
52 Week Range
1.00
2.42
Volume:11,500
Mkt Cap:8 M
Price Target
$1.17
+14.7%

Financial Statements

PMCB - Income Statement (Annual)

Apr-24Apr-23Apr-22Apr-21Apr-20Apr-19Apr-18Apr-17Apr-16Apr-14
Accretion On Preferred Stock15 M
Accrued Preferred Stock Dividends3 M
Acquisition Expense406812.0
Commission Expenses768000.0
Depreciation And Amortization406812.0
Development Expense65500.0
Earnings From Equity Interest5876.0
Earnings From Equity Interest Net Of Tax5876.0
Fees-45000.0
Gain On Sale Of PPE-2 M
General And Administrative Expense5 M5 M2 M1 M2 M2 M2 M1 M3 M3 M
Interest Expense Non Operating509.03046.0453.01539.01191.019963.0
Interest Expense Operating45000.0
Marketing Expense326540.065500.0
Misc Other Special Charges191145.0202002.0-4283.074791.0-40.033401.0152588.0-1539.010540.0-10 M
Net Income (loss)333763.0-4 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-27 M
Net Income Common Stockholders-17 M-4 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-27 M
Net Income Continuous Operations333763.0-4 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-27 M
Net Non Operating Interest Income Expense3 M2 M157136.0-3046.0-453.0-1539.0-1191.0-19963.0
Normalized Income-3 M-5 M-4 M
Operating Income-9 M-6 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-18 M
Operating Income Before Depreciation (EBITDA)333763.0-5 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-29 M
Operating Expense9 M6 M4 M4 M4 M-4 M-7 M-4 M-6 M-19 M
Other Gand A5 M5 M2 M1 M2 M2 M2 M1 M3 M3 M
Other Impairment Of Capital Assets2 M
Other Operating Expenses29546.023420.019341.020429.030964.0-4 M-6 M-19 M
Other Write Down326540.0768000.0
Otherunder Preferred Stock Dividend18 M
Preferred Stock Dividends18 M
Rent And Landing Fees1 M2 M744796.02 M2 M
Research Expense407431.0468536.0690937.0916249.0301221.0460052.02 M1 M1 M323500.0
Salaries And Wages1 M1 M2 M1 M2 M2 M2 M2 M2 M14 M
Selling And Marketing Expense326540.065500.0872200.0
Selling Expense872200.0
Total Income Available For Interest Expense (EBIT)333763.0-5 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-29 M
Total Expenses9 M6 M4 M4 M4 M-4 M-7 M4 M-6 M-19 M
Amord406812.0
Avgshs10 M19 M16 M1 M903811.0733402.0645761.0563539.0501602.0388813.0
Avgshsdt10 M19 M16 M1 M903811.0733402.0645761.0563539.0501602.0388813.0
Basiceps-1.8-0.22-0.27-2.45-75.0
Basicepscont-1.8-0.22-0.27-2.45
Depamor406812.0
Dileps-1.8-0.22-0.27-2.45-15.0-15.0-15.0
Dilepscont-1.8-0.22-0.27
Intinc3 M2 M157645.01090.0
Netincdisc333763.0-4 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-27 M
Othincexp3 M-202002.0-4283.0-74791.040.0-33401.0-152588.01539.0-10540.011 M
Pretaxinc-7 M-4 M-4 M-4 M-4 M-4 M-7 M-4 M-6 M-29 M
Resdev407431.0468536.0690937.0916249.0301221.0460052.02 M1 M1 M323500.0
Sga5 M5 M2 M1 M2 M2 M3 M1 M3 M4 M
Shsout8 M9 M21 M2 M2 M885447.0694025.0648778.0565369.0472837.0
Taxprov-906359.0-890224.0-745760.0-803646.0-6454.0-887749.0-195211.0-2 M